According to this study, over the next five years the Hemostatic Agents market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemostatic Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostatic Agents market by type, application, key manufacturers and key regions and countries.
This study considers the Hemostatic Agents value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Surgical Centers
Nursing Homes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ethicon
Gelita Medical
Pfizer
C. R. Bard
The Medicines Company
Baxter International
Integra LifeSciences
Anika Therapeutics
B Braun Melsungen
Advanced Medical Solutions
BioCer Entwicklungs
Biom’Up SAS
Equimedical
Z-Medica
Marine Polymer Technologies
CryoLife
Vascular Solutions
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemostatic Agents consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hemostatic Agents market by identifying its various subsegments.
Focuses on the key global Hemostatic Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemostatic Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemostatic Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemostatic Agents Consumption 2015-2025
2.1.2 Hemostatic Agents Consumption CAGR by Region
2.2 Hemostatic Agents Segment by Type
2.2.1 Gelation Sponge
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Others
2.3 Hemostatic Agents Consumption by Type
2.3.1 Global Hemostatic Agents Consumption Market Share by Type (2015-2020)
2.3.2 Global Hemostatic Agents Revenue and Market Share by Type (2015-2020)
2.3.3 Global Hemostatic Agents Sale Price by Type (2015-2020)
2.4 Hemostatic Agents Segment by Application
2.4.1 Hospitals
2.4.2 Surgical Centers
2.4.3 Nursing Homes
2.5 Hemostatic Agents Consumption by Application
2.5.1 Global Hemostatic Agents Consumption Market Share by Type (2015-2020)
2.5.2 Global Hemostatic Agents Value and Market Share by Type (2015-2020)
2.5.3 Global Hemostatic Agents Sale Price by Type (2015-2020)
3 Global Hemostatic Agents by Company
3.1 Global Hemostatic Agents Sales Market Share by Company
3.1.1 Global Hemostatic Agents Sales by Company (2018-2020)
3.1.2 Global Hemostatic Agents Sales Market Share by Company (2018-2020)
3.2 Global Hemostatic Agents Revenue Market Share by Company
3.2.1 Global Hemostatic Agents Revenue by Company (2018-2020)
3.2.2 Global Hemostatic Agents Revenue Market Share by Company (2018-2020)
3.3 Global Hemostatic Agents Sale Price by Company
3.4 Global Hemostatic Agents Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Hemostatic Agents Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Hemostatic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hemostatic Agents by Regions
4.1 Hemostatic Agents by Regions
4.2 Americas Hemostatic Agents Consumption Growth
4.3 APAC Hemostatic Agents Consumption Growth
4.4 Europe Hemostatic Agents Consumption Growth
4.5 Middle East & Africa Hemostatic Agents Consumption Growth
5 Americas
5.1 Americas Hemostatic Agents Consumption by Countries
5.1.1 Americas Hemostatic Agents Consumption by Countries (2015-2020)
5.1.2 Americas Hemostatic Agents Value by Countries (2015-2020)
5.2 Americas Hemostatic Agents Consumption by Type
5.3 Americas Hemostatic Agents Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hemostatic Agents Consumption by Regions
6.1.1 APAC Hemostatic Agents Consumption by Regions (2015-2020)
6.1.2 APAC Hemostatic Agents Value by Regions (2015-2020)
6.2 APAC Hemostatic Agents Consumption by Type
6.3 APAC Hemostatic Agents Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Hemostatic Agents by Countries
7.1.1 Europe Hemostatic Agents Consumption by Countries (2015-2020)
7.1.2 Europe Hemostatic Agents Value by Countries (2015-2020)
7.2 Europe Hemostatic Agents Consumption by Type
7.3 Europe Hemostatic Agents Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hemostatic Agents by Countries
8.1.1 Middle East & Africa Hemostatic Agents Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Hemostatic Agents Value by Countries (2015-2020)
8.2 Middle East & Africa Hemostatic Agents Consumption by Type
8.3 Middle East & Africa Hemostatic Agents Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hemostatic Agents Distributors
10.3 Hemostatic Agents Customer
11 Global Hemostatic Agents Market Forecast
11.1 Global Hemostatic Agents Consumption Forecast (2021-2025)
11.2 Global Hemostatic Agents Forecast by Regions
11.2.1 Global Hemostatic Agents Forecast by Regions (2021-2025)
11.2.2 Global Hemostatic Agents Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hemostatic Agents Forecast by Type
11.8 Global Hemostatic Agents Forecast by Application
12 Key Players Analysis
12.1 Ethicon
12.1.1 Company Information
12.1.2 Hemostatic Agents Product Offered
12.1.3 Ethicon Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Ethicon Latest Developments
12.2 Gelita Medical
12.2.1 Company Information
12.2.2 Hemostatic Agents Product Offered
12.2.3 Gelita Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Gelita Medical Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Hemostatic Agents Product Offered
12.3.3 Pfizer Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 C. R. Bard
12.4.1 Company Information
12.4.2 Hemostatic Agents Product Offered
12.4.3 C. R. Bard Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 C. R. Bard Latest Developments
12.5 The Medicines Company
12.5.1 Company Information
12.5.2 Hemostatic Agents Product Offered
12.5.3 The Medicines Company Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 The Medicines Company Latest Developments
12.6 Baxter International
12.6.1 Company Information
12.6.2 Hemostatic Agents Product Offered
12.6.3 Baxter International Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Baxter International Latest Developments
12.7 Integra LifeSciences
12.7.1 Company Information
12.7.2 Hemostatic Agents Product Offered
12.7.3 Integra LifeSciences Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Integra LifeSciences Latest Developments
12.8 Anika Therapeutics
12.8.1 Company Information
12.8.2 Hemostatic Agents Product Offered
12.8.3 Anika Therapeutics Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Anika Therapeutics Latest Developments
12.9 B Braun Melsungen
12.9.1 Company Information
12.9.2 Hemostatic Agents Product Offered
12.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 B Braun Melsungen Latest Developments
12.10 Advanced Medical Solutions
12.10.1 Company Information
12.10.2 Hemostatic Agents Product Offered
12.10.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Advanced Medical Solutions Latest Developments
12.11 BioCer Entwicklungs
12.11.1 Company Information
12.11.2 Hemostatic Agents Product Offered
12.11.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 BioCer Entwicklungs Latest Developments
12.12 Biom’Up SAS
12.12.1 Company Information
12.12.2 Hemostatic Agents Product Offered
12.12.3 Biom’Up SAS Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Biom’Up SAS Latest Developments
12.13 Equimedical
12.13.1 Company Information
12.13.2 Hemostatic Agents Product Offered
12.13.3 Equimedical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Equimedical Latest Developments
12.14 Z-Medica
12.14.1 Company Information
12.14.2 Hemostatic Agents Product Offered
12.14.3 Z-Medica Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Z-Medica Latest Developments
12.15 Marine Polymer Technologies
12.15.1 Company Information
12.15.2 Hemostatic Agents Product Offered
12.15.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Marine Polymer Technologies Latest Developments
12.16 CryoLife
12.16.1 Company Information
12.16.2 Hemostatic Agents Product Offered
12.16.3 CryoLife Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 CryoLife Latest Developments
12.17 Vascular Solutions
12.17.1 Company Information
12.17.2 Hemostatic Agents Product Offered
12.17.3 Vascular Solutions Hemostatic Agents Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Vascular Solutions Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Hemostatic Agents Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of G